Holen Sie sich die Stockscreener-App
0.2724
4.59%
-0.0131
Handel nachbörslich:
.28
0.0076
+2.79%
Schlusskurs vom Vortag:
$0.2855
Offen:
$0.286
24-Stunden-Volumen:
675.82K
Relative Volume:
0.28
Marktkapitalisierung:
$9.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.0233
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
-1.63%
1M Leistung:
+20.48%
6M Leistung:
-61.09%
1J Leistung:
-85.89%
1-Tages-Spanne:
$0.2625
$0.2872
1-Wochen-Bereich:
$0.248
$0.29
52-Wochen-Spanne:
$0.2023
$3.97
Genprex Inc Stock (GNPX) Company Profile
Firmenname
Genprex Inc
Sektor
Branche
Telefon
512-537-7997
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Vergleichen Sie GNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.2724 | 9.55M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | National Securities | Buy |
| 2019-04-29 | Eingeleitet | Noble Capital Markets | Outperform |
Genprex Inc Aktie (GNPX) Neueste Nachrichten
What makes Genprex Inc. stock price move sharplyMaximize returns with smart investment plans - jammulinksnews.com
Is Genprex Inc. a growth stock or a value stockInvest confidently with real-time market updates - jammulinksnews.com
What institutional investors are buying Genprex Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com
How volatile is Genprex Inc. stock compared to the marketTremendous return on equity - jammulinksnews.com
What catalysts could drive Genprex Inc. stock higher in 2025Free Investment Community - jammulinksnews.com
Will Genprex Inc. stock benefit from interest rate changesFree Stock Market Courses - Newser
How Genprex Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
What drives Genprex Inc. stock priceFree Expert Stock Watchlist - PrintWeekIndia
Genprex Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia
What analysts say about Genprex Inc. stockExponentially increasing returns - Autocar Professional
Is Genprex Inc. a good long term investmentGame-changing returns - jammulinksnews.com
Genprex (NASDAQ:GNPX) Stock Price Down 3.2% – Should You Sell? - Defense World
Why Genprex Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
Genprex Collaborators Present Positive Preclinical Research on D - GuruFocus
Genprex (GNPX) Unveils Promising Preclinical Results for Diabetes Therapy | GNPX Stock News - GuruFocus
Genprex (GNPX) Unveils Promising Data for Diabetes Gene Therapy | GNPX Stock News - GuruFocus
Genprex Announces Positive Data for Diabetes Therapy - TipRanks
Genprex's Strategic Share Sale: Balancing Dilution Risks with Clinical Milestones - AInvest
Genprex Enters $12.5M Stock Purchase Agreement - TipRanks
Genprex (GNPX) Announces Plan to Sell 15 Million Shares | GNPX Stock News - GuruFocus
Genprex Files for Resale of 15 Million Shares - MarketScreener
Finanzdaten der Genprex Inc-Aktie (GNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):